Samantha G. Zambuto, Adrienne K. Scott, Michelle L. Oyen
{"title":"FDA Modernization Act 2.0 and reproductive research","authors":"Samantha G. Zambuto, Adrienne K. Scott, Michelle L. Oyen","doi":"10.1038/s44222-024-00252-8","DOIUrl":null,"url":null,"abstract":"The FDA Modernization Act 2.0 allows bioengineered models in drug testing, including benchtop testing and computational models. These alternatives to animal testing may particularly advance drug discovery in reproductive and pregnancy research.","PeriodicalId":74248,"journal":{"name":"Nature reviews bioengineering","volume":"2 12","pages":"984-986"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature reviews bioengineering","FirstCategoryId":"1085","ListUrlMain":"https://www.nature.com/articles/s44222-024-00252-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The FDA Modernization Act 2.0 allows bioengineered models in drug testing, including benchtop testing and computational models. These alternatives to animal testing may particularly advance drug discovery in reproductive and pregnancy research.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
